| scholarly article | Q13442814 |
| P356 | DOI | 10.1089/HUM.2005.16.509 |
| P698 | PubMed publication ID | 15871682 |
| P2093 | author name string | Patrick Aebischer | |
| Clive N Svendsen | |||
| Masatoshi Suzuki | |||
| Jacalyn McHugh | |||
| Sandra M Klein | |||
| Kristin Hoffmann | |||
| Kyle Wallace | |||
| Soshana Behrstock | |||
| P433 | issue | 4 | |
| P921 | main subject | amyotrophic lateral sclerosis | Q206901 |
| P304 | page(s) | 509-521 | |
| P577 | publication date | 2005-04-01 | |
| P1433 | published in | Human Gene Therapy | Q15757580 |
| P1476 | title | GDNF delivery using human neural progenitor cells in a rat model of ALS. | |
| P478 | volume | 16 |
| Q34122934 | "A novel in vivo model for the study of human breast cancer metastasis using primary breast tumor-initiating cells from patient biopsies". |
| Q94029143 | A Preview of Selected Articles |
| Q36111849 | Achieving stable human stem cell engraftment and survival in the CNS: is the future of regenerative medicine immunodeficient? |
| Q33729764 | Acute glial activation by stab injuries does not lead to overt damage or motor neuron degeneration in the G93A mutant SOD1 rat model of amyotrophic lateral sclerosis |
| Q38160459 | Amyotrophic lateral sclerosis: applications of stem cells - an update. |
| Q39774211 | Ape1/Ref-1 Stimulates GDNF/GFRalpha1-mediated Downstream Signaling and Neuroblastoma Proliferation |
| Q34568739 | Autologous mesenchymal stem cells: clinical applications in amyotrophic lateral sclerosis |
| Q38068560 | Cell therapy: the final frontier for treatment of neurological diseases. |
| Q39946077 | Cell-Based Neurorestorotherapy in Amyotrophic Lateral Sclerosis - Scientific Truth should Rely on Facts, but Not Conjecture |
| Q48415970 | Chapter 55: neural transplantation |
| Q37871429 | Current challenges for the advancement of neural stem cell biology and transplantation research. |
| Q26861926 | Current concept in neural regeneration research: NSCs isolation, characterization and transplantation in various neurodegenerative diseases and stroke: A review |
| Q38210852 | Developments in treatments for amyotrophic lateral sclerosis via intracerebroventricular or intrathecal delivery |
| Q34903874 | Differential expression of c-Ret in motor neurons versus non-neuronal cells is linked to the pathogenesis of ALS. |
| Q37183861 | Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS |
| Q38765043 | Disruption of the astrocytic TNFR1-GDNF axis accelerates motor neuron degeneration and disease progression in amyotrophic lateral sclerosis. |
| Q34994432 | Dual transplantation of human neural stem cells into cervical and lumbar cord ameliorates motor neuron disease in SOD1 transgenic rats |
| Q42121731 | Effects of resveratrol on hydrogen peroxide-induced oxidative stress in embryonic neural stem cells. |
| Q39645967 | Efficient Transduction of Feline Neural Progenitor Cells for Delivery of Glial Cell Line-Derived Neurotrophic Factor Using a Feline Immunodeficiency Virus-Based Lentiviral Construct |
| Q35730391 | Enhanced de novo neurogenesis and dopaminergic neurogenesis in the substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease-like mice |
| Q34093834 | Enteric glial cells and their role in the intestinal epithelial barrier |
| Q39355264 | Feline neural progenitor cells II: use of novel plasmid vector and hybrid promoter to drive expression of glial cell line-derived neurotrophic factor transgene |
| Q33722252 | Ferumoxytol Labeling of Human Neural Progenitor Cells for Diagnostic Cellular Tracking in the Porcine Spinal Cord with Magnetic Resonance Imaging. |
| Q42188656 | Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease |
| Q38015343 | Functional multipotency of stem cells: a conceptual review of neurotrophic factor-based evidence and its role in translational research |
| Q40204577 | GDNF reduces oxidative stress in a 6-hydroxydopamine model of Parkinson's disease |
| Q33292690 | GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS. |
| Q36350210 | Gene therapy: can neural stem cells deliver? |
| Q92418503 | Glial Cell Line-derived Neurotrophic Factor-overexpressing Human Neural Stem/Progenitor Cells Enhance Therapeutic Efficiency in Rat with Traumatic Spinal Cord Injury |
| Q38551398 | Glial cell line-derived neurotrophic factor-secreting human neural progenitors show long-term survival, maturation into astrocytes, and no tumor formation following transplantation into the spinal cord of immunocompromised rats |
| Q36816782 | Gonadectomy and dehydroepiandrosterone (DHEA) do not modulate disease progression in the G93A mutant SOD1 rat model of amyotrophic lateral sclerosis |
| Q37290026 | Growth factor-expressing human neural progenitor cell grafts protect motor neurons but do not ameliorate motor performance and survival in ALS mice. |
| Q34978654 | Human amniotic fluid stem cells have a potential to recover ovarian function in mice with chemotherapy-induced sterility |
| Q33804981 | Human induced pluripotent stem cells are a novel source of neural progenitor cells (iNPCs) that migrate and integrate in the rodent spinal cord |
| Q33614725 | Human nerual stem cells for brain repair |
| Q40339968 | Human neural progenitors deliver glial cell line-derived neurotrophic factor to parkinsonian rodents and aged primates |
| Q37307371 | Human neural stem cell grafts in the spinal cord of SOD1 transgenic rats: differentiation and structural integration into the segmental motor circuitry |
| Q39998379 | Huperzine A provides neuroprotection against several cell death inducers using in vitro model systems of motor neuron cell death |
| Q38883240 | Immunization with a Myelin-Derived Antigen Activates the Brain's Choroid Plexus for Recruitment of Immunoregulatory Cells to the CNS and Attenuates Disease Progression in a Mouse Model of ALS. |
| Q37315468 | In Vivo Tracking of Human Neural Progenitor Cells in the Rat Brain Using Magnetic Resonance Imaging Is Not Enhanced by Ferritin Expression |
| Q53070596 | Inducible Expression of GDNF in Transplanted iPSC-Derived Neural Progenitor Cells. |
| Q39220513 | Inducible regulation of GDNF expression in human neural stem cells |
| Q37070017 | Intermittent hypoxia and stem cell implants preserve breathing capacity in a rodent model of amyotrophic lateral sclerosis |
| Q51012646 | Intraspinal administration of human spinal cord-derived neural progenitor cells in the G93A-SOD1 mouse model of ALS delays symptom progression, prolongs survival and increases expression of endogenous neurotrophic factors. |
| Q45887127 | Intrathecal transplantation of human neural stem cells overexpressing VEGF provide behavioral improvement, disease onset delay and survival extension in transgenic ALS mice |
| Q42948093 | Lentivirus‐mediated expression of insulin‐like growth factor‐I promotes neural stem/precursor cell proliferation and enhances their potential to generate neurons |
| Q39910617 | Lesion-induced increase in survival and migration of human neural progenitor cells releasing GDNF. |
| Q39978206 | Long-term multilayer adherent network (MAN) expansion, maintenance, and characterization, chemical and genetic manipulation, and transplantation of human fetal forebrain neural stem cells |
| Q43211527 | Long-term transgene expression in mouse neural progenitor cells modified with phiC31 integrase |
| Q50187803 | Magnetic Resonance Imaging-Guided Transplantation of Neural Stem Cells into the Porcine Spinal Cord |
| Q33858257 | Measures of bulbar and spinal motor function, muscle innervation, and mitochondrial function in ALS rats |
| Q36553868 | Melittin-grafted HPMA-oligolysine based copolymers for gene delivery |
| Q39913801 | Mesenchymal stem cells as trojan horses for GDNF delivery in ALS. |
| Q34473474 | Mesenchymal stem cells for the treatment of neurodegenerative disease. |
| Q35540393 | Model systems of motor neuron diseases as a platform for studying pathogenic mechanisms and searching for therapeutic agents |
| Q47152662 | Motor Neuron Gene Therapy: Lessons from Spinal Muscular Atrophy for Amyotrophic Lateral Sclerosis |
| Q26822886 | Motor neuron derivation from human embryonic and induced pluripotent stem cells: experimental approaches and clinical perspectives |
| Q37638358 | Neonatal immune-tolerance in mice does not prevent xenograft rejection |
| Q38079295 | Neural stem cell-based treatment for neurodegenerative diseases |
| Q48199408 | Neural stem cells LewisX+ CXCR4+ modify disease progression in an amyotrophic lateral sclerosis model. |
| Q35576478 | Neural stem cells: historical perspective and future prospects. |
| Q36748869 | Neurodegeneration and cell replacement. |
| Q36334459 | Neurogenic responses to amyloid-beta plaques in the brain of Alzheimer's disease-like transgenic (pPDGF-APPSw,Ind) mice |
| Q34222849 | Neuroprotection for amyotrophic lateral sclerosis: role of stem cells, growth factors, and gene therapy |
| Q37322226 | Neurotrophic factors in neurodegenerative disorders : potential for therapy |
| Q36389277 | New frontiers in human cell biology and medicine: can pluripotent stem cells deliver? |
| Q96952560 | Next-generation stem cells - ushering in a new era of cell-based therapies |
| Q51450955 | Optimization of immunosuppressive therapy for spinal grafting of human spinal stem cells in a rat model of ALS. |
| Q39463659 | Optimized quantities of GDNF overexpressed by engineered astrocytes are critical for protection of neuroblastoma cells against 6-OHDA toxicity |
| Q92712171 | Past and Future of Neurotrophic Growth Factors Therapies in ALS: From Single Neurotrophic Growth Factor to Stem Cells and Human Platelet Lysates |
| Q37264786 | Pathological classification of human iPSC-derived neural stem/progenitor cells towards safety assessment of transplantation therapy for CNS diseases |
| Q38733015 | Patients with ALS show highly correlated progression rates in left and right limb muscles |
| Q39457264 | Pericyte-derived glial cell line-derived neurotrophic factor increase the expression of claudin-5 in the blood-brain barrier and the blood-nerve barrier |
| Q26776154 | Potential of Neural Stem Cell-Based Therapy for Parkinson's Disease |
| Q36883767 | Potential roles of bone marrow stem cells in stroke therapy |
| Q34276055 | Potential therapeutic drugs and methods for the treatment of amyotrophic lateral sclerosis |
| Q43679121 | Preclinical Validation of Multilevel Intraparenchymal Stem Cell Therapy in the Porcine Spinal Cord |
| Q33280574 | Protection of visual functions by human neural progenitors in a rat model of retinal disease |
| Q90590738 | Quantification of motor neuron loss and muscular atrophy in ricin-induced focal nerve injury |
| Q27318549 | Real time imaging of human progenitor neurogenesis |
| Q27338320 | Recent Advances and the Future of Stem Cell Therapies in Amyotrophic Lateral Sclerosis |
| Q36117618 | Recent advances in amyotrophic lateral sclerosis research: perspectives for personalized clinical application |
| Q38241625 | Recent advances of stem cell therapy for retinitis pigmentosa |
| Q52558375 | Safety and Feasibility of Lin- Cells Administration to ALS Patients: A Novel View on Humoral Factors and miRNA Profiles. |
| Q36249538 | Secretoneurin promotes neuroprotection and neuronal plasticity via the Jak2/Stat3 pathway in murine models of stroke |
| Q40233416 | Sexual dimorphism in disease onset and progression of a rat model of ALS. |
| Q37120161 | Stem and progenitor cell-mediated tumor selective gene therapy |
| Q38057870 | Stem cell applications in regenerative medicine for neurological disorders |
| Q37109618 | Stem cell sources and therapeutic approaches for central nervous system and neural retinal disorders |
| Q37851503 | Stem cell technology for the study and treatment of motor neuron diseases. |
| Q38202011 | Stem cell transplantation for amyotrophic lateral sclerosis: therapeutic potential and perspectives on clinical translation. |
| Q33919781 | Stem cell-derived motor neurons: applications and challenges in amyotrophic lateral sclerosis |
| Q37053159 | Stem cells and neurological diseases. |
| Q28249501 | Stem cells for the treatment of neurological disorders |
| Q37575591 | Stem cells in amyotrophic lateral sclerosis: state of the art. |
| Q27687068 | Stem cells in human neurodegenerative disorders--time for clinical translation? |
| Q38630465 | Stem cells therapy for ALS. |
| Q37417183 | Stem cells: comprehensive treatments for amyotrophic lateral sclerosis in conjunction with growth factor delivery. |
| Q48852540 | Stem-cell therapies: the first wave. |
| Q39471822 | Suppression of Etk/Bmx protects against ischemic brain injury |
| Q33600773 | Systemic injection of AAV9-GDNF provides modest functional improvements in the SOD1G93A ALS rat but has adverse side effects. |
| Q36419592 | Therapeutic targets for amyotrophic lateral sclerosis: current treatments and prospects for more effective therapies |
| Q43297575 | Transient recovery in a rat model of familial amyotrophic lateral sclerosis after transplantation of motor neurons derived from mouse embryonic stem cells |
| Q59001351 | Translational Research in Stem Cell Treatment of Neuromuscular Diseases |
| Q26825854 | Transplantation of stem cell-derived astrocytes for the treatment of amyotrophic lateral sclerosis and spinal cord injury |
| Q56816719 | Transplanted neural progenitor cells survive and differentiate but achieve limited functional recovery in the lesioned adult rat spinal cord |
Search more.